Evidence map›Paper›PMID 30758857›Full record

Observational studyClinical and experimental immunology2019

Antibody responses to Bordetella pertussis and other childhood vaccines in infants born to mothers who received pertussis vaccine in pregnancy - a prospective, observational cohort study from the United Kingdom.

T F Rice, D A Diavatopoulos, G P Smits, P G M van Gageldonk, G A M Berbers, F R van der Klis, G Vamvakas, B Donaldson, M Bouqueau, B Holder and 1 more

Open access · hybridAbstract readObservational Study
In one paragraph

Observational study in Clinical and experimental immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 2 pooled it
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 2 syntheses or guidelines pooled it, 32 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Anti-FIM and Anti-FHA Antibodies InhibitFrontiers in immunology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 3 countries.

T F RiceSection of Paediatrics, Department of Medicine, Imperial College London, UK.
D A DiavatopoulosSection for Pediatric Infectious Diseases, Laboratory of Medical Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.
G P SmitsCentre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
P G M van GageldonkCentre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
G A M BerbersCentre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
F R van der KlisCentre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
G VamvakasDepartment of Biostatistics, Institute of Psychology, Psychiatry and Neuroscience, King's College London, UK.
B DonaldsonSection of Paediatrics, Department of Medicine, Imperial College London, UK.
M BouqueauSection of Paediatrics, Department of Medicine, Imperial College London, UK.
B HolderSection of Paediatrics, Department of Medicine, Imperial College London, UK.ORCID 0000-0003-2157-9819
B KampmannSection of Paediatrics, Department of Medicine, Imperial College London, UK.ORCID 0000-0002-6546-4709
Imperial College London · GBNational Institute for Public Health and the Environment · NLKing's College London · GBLondon School of Hygiene & Tropical Medicine · GBRadboud University Nijmegen · NL

Funding

Biotechnology and Biological Sciences Research CouncilDepartment of Health P72781Medical Research Council MC_PC_17221Medical Research Council MC_UP_A900_1122Medical Research Council MC_UU_00026/2Medical Research Council MR/K007602/1
6 · The paper itself

Abstract

The maternal Tdap (tetanus, diphtheria and acellular pertussis) vaccination programme in the United Kingdom has successfully reduced cases of pertussis in young infants. In addition to prevention of pertussis cases, it is also important to investigate the persistence of maternal antibodies during infancy and the possible interference of maternal antibodies with infant responses to vaccines. We recruited mother-infant pairs from vaccinated and unvaccinated pregnancies and measured concentrations of immunoglobulin (Ig)G against pertussis toxin (PTx), filamentous haemagglutinin (FHA), pertactin (Prn), diphtheria toxin (DTx), tetanus toxoid (TTx) Haemophilus influenzae type b (Hib) and Streptococcus pneumoniae in mothers and infants at birth, and in infants at 7 weeks and at 5 months. Thirty-one mother-infant pairs were tested. Tdap-vaccinated women had significantly higher antibody against Tdap antigens, compared to unvaccinated women (DTx, P = 0·01; PTx, FHA, Prn and TTx, P < 0·001). All antibodies were actively transferred to the infants (transfer ratio  > 1) with higher transfer of DTx (P = 0·04) and TTx (P = 0·02) antibody in Tdap-vaccinated pregnancies compared to unvaccinated pregnancies. Infants from Tdap-vaccinated pregnancies had significantly elevated antibodies to all antigens at birth (P < 0.001) and at 7 weeks (FHA, Prn, TTx, P < 0·001; DTx, P = 0.01; PTx, P = 0·004) compared to infants from unvaccinated pregnancies. Infants from Tdap-vaccinated and -unvaccinated pregnancies had comparable antibody concentrations following primary pertussis immunization (PTx, P = 0·77; FHA, P = 0·58; Prn, P = 0·60; DTx, P = 0·09; TTx, P = 0·88). These results support maternal immunization as a method of protecting vulnerable infants during their first weeks of life.

Indexed as

Immunity, Maternally-AcquiredAntibodies, BacterialAntibody SpecificityAntigens, BacterialBacterial VaccinesBordetella pertussisCohort StudiesDiphtheria-Tetanus-acellular Pertussis VaccinesFemaleHaemophilus influenzae type bHumansImmunization ScheduleImmunization, SecondaryInfantInfant, NewbornMaternal-Fetal ExchangeAntibodies, BacterialAntigens, BacterialBacterial VaccinesDiphtheria-Tetanus-acellular Pertussis VaccinesPertussis Vaccineantibodieshumanreproductive immunologyvaccination

Identifiers

PMID30758857
PMCPMC6591149
OpenAlexW2942574203

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.